A AddLife AB
A
Uždarymo kaina
144 -3.55
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
140.6
Max
149.3
Pajamos | -31M 229M |
|---|---|
Pardavimai | -88M 2.6B |
P/E Sektoriaus vid. | 32.64 99.24 |
Pelnas, tenkantis vienai akcijai | 1.04 |
Dividendų pajamingumas | 0.98 |
Pelno marža | 8.658 |
Darbuotojai | 2,295 |
EBITDA | -373M 229M |
Dividendų pajamingumas Sektoriaus vid. | 0.98% 2.54% |
|---|
Rinkos kapitalizacija | 951M 19B |
|---|---|
Ankstesnė atidarymo kaina | 147.55 |
Ankstesnė uždarymo kaina | 144 |
AddLife AB Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Susijusios naujienos
Akcijų palyginimas
Kainos pokytis
AddLife AB Prognozė
Finansinės naujienos
Pardavimo ir administravimo išlaidos
Veiklos sąnaudos
Ikimokestinis pelnas
Pardavimai
Pardavimo savikaina
Bendrasis pelnas iš pardavimo
Skolų palūkanų išlaidos
EBITDA
Veiklos pelnas
$
Apie bendrovę AddLife AB
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
